CLINICAL_TRIALS
trial_result
· 2023-06-22
Clinical Trial Update: Sequential Belimumab and T-cell Based Therapy in SLE [Phase 4]
Summary
Phase 4 clinical trial update investigating sequential belimumab followed by a T-cell based therapy for systemic lupus erythematosus (SLE).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National University Hospital, Singapore | Conditions: Systemic Lupus Erythematosus | Phase 4 | Status: UNKNOWN